Document Detail


Does the benefit from statin therapy extend beyond 5 years?
MedLine Citation:
PMID:  23299638     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Large randomized trials have shown that lowering the concentration of LDL cholesterol with statins reduces vascular morbidity and mortality rapidly, with further benefit emerging during each year of treatment allocation. But, limited evidence is available about the long-term efficacy and safety of statin treatment. Long-term follow-up of surviving trial participants allows direct assessment of the benefits (and any hazards) of a sustained reduction in LDL cholesterol concentration during the post-trial period. Post-trial follow-up of several large statin trials (of which the Heart Protection Study was the largest) confirms that the substantial absolute benefits and cost-effectiveness of statin therapy were, in fact, underestimated in previous analyses restricted to the "in-trial" periods of randomized studies. Reassuringly, no adverse effects on cancer incidence or non-vascular mortality emerged during the extended follow-up of the Heart Protection Study. These findings support the prompt initiation and long-term continuation of statin therapy in individuals at increased vascular risk.
Authors:
Richard Bulbulia; Jane Armitage
Related Documents :
17460488 - Effectiveness and safety of lactobacillus lb in the treatment of mild acute diarrhea in...
24904018 - Cost-effectiveness of clopidogrel-aspirin versus aspirin alone for acute transient isch...
22914208 - The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005%...
23378778 - Medical costs and utilization in patients with depression treated with adjunctive atypi...
18695078 - Long-term clinical outcomes following coronary stenting.
23979148 - The integral theory system questionnaire: an anatomically directed questionnaire to det...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current atherosclerosis reports     Volume:  15     ISSN:  1534-6242     ISO Abbreviation:  Curr Atheroscler Rep     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-09     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100897685     Medline TA:  Curr Atheroscler Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  297     Citation Subset:  IM    
Affiliation:
Clinical Trial Service Unit, University of Oxford, Richard Doll Building, Old Road Campus Headington, Oxford, OX3 7LF, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  45,X mosaicism in northeast China: a clinical report and review of the literature.
Next Document:  The evolution or revolution of statin therapy in primary prevention: where do we go from here?